Phase Genomics announced it raised $4.75 Million in an initial filing from an offering of $6.58 Million
Phase Genomics announced it raised $4.75 Million in an initial filing from an offering of $6.58 Million
03/21/23, 9:26 PM
Location
seattle
Money raised
$4.75 million
Industry
science and engineering
data and analytics
Round Type
seed
Company Info
Location
4000 mason road
seattle, washington, united states
Additional Info
Phase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software.
Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.